Compare Eli Lilly And Co (LLY) vs Trane Technologies plc (TT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Trane Technologies plc — how do they compare? Eli Lilly And Co trades at $1,212 (market cap $1.04T), while Trane Technologies plc trades at $471.29 (market cap $105.17B). The key difference: Eli Lilly And Co is far larger — about 9.9× Trane Technologies plc's market cap, and Trane Technologies plc pays the higher dividend (0.88%). Which is the better fit depends on your goals.
| LLY | TT | |
|---|---|---|
Market Cap | $1.04T | $105.17B |
Volume | 1,843,375 | 1,040,183 |
Sector | Health | Industrials |
52-Week High | $1.28K | $503.46 |
52-Week Low | $799.57 | $376.43 |
Typical Hold Time | 94 Days | — |
Enterprise Value | $1.09T | $108.47B |
Dividend Yield | 0.59% | 0.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,211.40, up 2.43% today, with a bullish technical outlook and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 surpassing the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights pipeline advancements in weight-loss drugs, including EloraTZP's promising trial results.
Outlook remains positive given dominant market position in obesity and diabetes treatments, with analyst consensus price target of $1,350 implying ~11% upside. Key risks include competitive pressures from Novo Nordisk and regulatory hurdles. Earnings growth and pipeline catalysts support further appreciation, though high valuations warrant monitoring.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Trane Technologies plc
Trane Technologies plc is a global climate solutions company that designs, manufactures, and services heating, ventilation, and air conditioning (HVAC) and transport refrigeration equipment under its Trane and Thermo King brands.
Read more on TT →
